HEALTH● LOWJun 23 · Jun 23, 2026, 11:00 AM
Pfizer lung cancer therapy fails in late-stage trial versus chemotherapy
Seeking Alpha Tech
Pfizer's late-stage clinical trial for a lung cancer therapy failed when compared against chemotherapy. This outcome represents a setback for the development of new lung cancer treatments by the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH53m agoACA marketplace premiums rising by 13% in 2027Seeking Alpha TechHEALTH1h agoBaking soda and sugar against cockroaches: how to prepare the mixture and where to place itClarínHEALTH2h agoNIPRD records gains in research, staff welfare, public healthPremium TimesHEALTH2h agoMarta Barranco, psychologist: "We must learn to have high standards knowing that no one is perfect and that we can make mistakes, but there are minimums that must be respected"Clarín